Interim FDG PET/CT in primary mediastinal diffuse large B-cell lymphoma: really almost useless procedure?
- 232 Downloads
We read with great interest the results of a retrospective analysis of interim FDG PET/CT in patients with primary mediastinal B-cell lymphoma (PMBCL) by Lazarovici et al. . This paper could have an extraordinary impact on decision making in clinical practice worldwide. To investigate the prognostic value of interim PET in PMBCL, Lazarovici et al. analysed 36 consecutive patients who underwent PET/CT after four cycles of rituximab/anthracycline-containing regimens (mainly R-ACVBP or R-CHOP). They concluded that interim PET-positive results do not reflect persistence of active disease in the majority of patients. We fully agree with their statement that interim FDG PET/CT in PMBCL has a low positive prognostic value. But there are some major methodological drawbacks which should be clarified before one can accept that “the relapse rate appears similar regardless of interim FDG PET/CT results and interpretation criteria”, as the authors claimed.
First, the PET results were...
Compliance with ethical standards
Conflicts of interest
This article does not describe any studies with human participants performed by any of the authors.
- 2.Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007;25(5):571–8.CrossRefPubMedGoogle Scholar
- 6.Procházka V, Henzlová L, Buriánková E, Prouzová Z, Obr A, Novák M, et al. Prognostic impact of interim and final PET in primary mediastinal large B-Cell lymphoma treated with intensive etoposide-based therapy. Blood. 2014;124(21):1729.Google Scholar
- 10.Minamimoto R, Fayad L, Advani R, Vose J, Macapinlac H, Meza J, et al. Diffuse large B-cell lymphoma: prospective multicenter comparison of early interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST criteria for early therapeutic monitoring. Radiology. 2016;280(1):220–9.CrossRefPubMedPubMedCentralGoogle Scholar